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Abstract: The antimutagenic effect of ascorbic acid (vitamin C) was investigated by using the Drosophila wing spot test. In this assay,
3-day-old transheterozygous larvae for the multiple wing hair (mwh, 3-0.3) and flare (flr, 3-38.8) genes were treated with 3 direct
acting mutagens: ethyl methanesulfonate (EMS), methyl methanesulfonate (MMS) and N-nitroso N-ethylurea (ENU). The results
obtained from 3 reference mutagens were clearly genotoxic in the Drosophila wing somatic mutation and recombination test. The
calculated concentration of ascorbic acid as recommended dietary allowance (RDA) did not induce the frequency of the mutant clones
recorded. When co-treatment experiments with ascorbic acid were carried out, ascorbic acid was effective in reducing the
genotoxicity of the 3 direct acting mutagens.
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Askorbik Asitin Üç Alkilleyici Ajan›n Mutajenik Dozuna Anti-Genotoksik Etkisi
Özet: Bu çal›flmada askorbik asitin antimutajenik etkisi Drozofila kanat benek testi kullan›larak araflt›r›ld›. Bu çal›flmada, “multiple
wing hairs” (mwh, 3-0,3) ve “flare” (flr, 3-38,8) genleri bak›m›ndan 3-günlük transheterozigot larvalara do¤rudan etkileyen
mutajenler; etil metansülfonat (EMS), metil metansülfonat (MMS) ve N-nitrozo N-etilüre (ENU) uygulamas› yap›ld›. Drozofila Kanat
Somatik Mutasyon ve Rekombinasyon Testinde elde edilen sonuçlar bu üç mutajenin aç›kça genotoksik etkiye sahip oldu¤unu
gösterdi. Askorbik asitin günlük al›nmas› tavsiye edilen miktar›na (RDA) göre hesaplanan konsantrasyon mutant klon frekans›n›
indüklemedi. Askorbik asitle mutajenler birlikte uyguland›¤›nda, askorbik asit bu üç mutajenin genotoksik etkisinin azalmas›nda etkili
oldu.
Anahtar Sözcükler: Drozofila, askorbik asit, antigenotoksisite, somatic hücreler

Introduction
The expression of mutation associated with genotoxic
effects is the result of the interplay between risk factors
and the responses of the host organism. These processes
can be influenced by dietary agents such as
micronutrients. Approximately 40 micronutrients (the
vitamins, essential minerals and other compounds
required in small amounts for normal metabolism) are
required in the diet (1). Many epidemiological and
experimental studies indicate that diets rich in antioxidant
micronutrients may reduce the risk of certain types of
cancer and mutation (2-6). Diet may well be a key factor
in determining genomic stability since it impacts on all
relevant pathways i.e. exposure to dietary carcinogens,
activation/detoxification of carcinogens, DNA repair, DNA
synthesis and apoptosis (7). Many environmental and
chemical mutagens cause genetic damage (8-13) resulting

in reduced egg and milk production (14,15), reductions
in body weight (16) and sperm shape abnormalities (17)
in animals. Many micronutrients act as substrate and/or
co-factors in key DNA maintenance reactions, and the
exact concentration of these in the cell may be critical.
Vitamins are very important as micronutrients in
protecting macromolecules. One important micronutrient
is ascorbic acid, which functions as a factor in several
metabolic reactions such as post-translational
modification, carnitine and noradrenalin synthesis, and
tyrosine catabolism (18).
Various studies have been performed during recent
years to investigate the genotoxic or antigenotoxic
properties of ascorbic acid, as summarized in several
detailed reviews (19-21). Most of the reported data
indicate that ascorbic acid is antimutagenic in both in vitro
and in vivo tests, i.e. in different eukaryotic tissues (22)
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in human lymphocytes (23), in the Allium micronucleus
test (24) and also in Drosophila assays (25). Although
antioxidant protection is assumed for ascorbic acid
against oxidative damage, under different conditions
ascorbic acid seems to have co-genotoxic activity instead
of the normal antigenotoxic action. Thus, it can promote
the generation of oxygen radical-induced sister-chromatid
exchanges in cultured mammalian cells (26), as well as
some other types of genetic damage (22, 27). This would
indicate that more experimentation is required to
understand the antimutagenic and comutagenic action of
ascorbic acid.
To increase our knowledge of the antigenotoxic action
of ascorbic acid, we performed co-treatments with 3
direct acting mutagens ethyl methanesulfonate (EMS),
methyl methanesulfonate (MMS) and N-nitroso Nethylurea (ENU). The ascorbic acid concentration (17
mM) was calculated as recommended dietary allowance
(RDA) (28). We chose the Drosophila somatic mutation
and recombination test (SMART) due to the many
advantages that this eukaryotic organism has shown in in
vivo genotoxicity testing studies (29). Thus, the wing
variant of the SMART assay has proved to be a good tool
to detect a broad range of genetic alterations in a fast and
inexpensive way (30, 31)

Materials and Methods

Chemicals
The mutagens used in this study were EMS, MMS,
ENU and L-ascorbik acid supplied by Sigma Chemical Co.
(St. Louis, USA) Once the genotoxicity of the 3 selected
direct acting mutagens was known, only one dose for
each chemical tested was used in a co-treatment
experiment with a 17 mM concentration of ascorbic acid.
All the chemicals were prepared just before use. Distilled
water was used as a negative control.

Strains
The principles and basic procedures for the Drosophila
wing spot test have been described by Graf et al. (30).
The transheterozygous larvae were obtained by crossing
mwh/mwh males and flr3/TM3, BdS virgin females. For
detailed information on the genetic symbols and markers
see Lindsley and Zimm (32).

Experimental Procedure
Eggs from the cross between mwh males and flr3
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virgin females were collected over 8-h periods, and 72 ±
4 h later the resulting larvae were floated off with tap
water and recollected. After that, larvae were transferred
into plastic vials containing 4.5 g of Drosophila instant
medium (Carolina Biological Supply, Burlington, NC, USA)
re-hydrated with 9 ml of the respective test solutions
(mutagen, ascorbic acid, mutagen + ascorbic acid, and
distilled water for the negative controls). All experiments
were performed at 25 ± 1 oC and at approximately 60 %
relative humidity.
The emerging flies were collected and stored in 70 %
ethanol. Afterwards their wings were removed, mounted
in Faure´s solution on microscope slides and inspected
under 400x magnification for the presence of clones of
cells showing malformed wing hairs. The mutant clones
were classified into 3 types: (1) small single spots,
containing 1 or 2 cells; (2) large single spots, containing
3 or more cells; and (3) twin spots, containing adjacent
mwh and flr3 cells (30). A total of 80 wings were
examined for each concentration.

Statistical analysis
For the evaluation of the induced effects, the
frequencies of spots per wing were analyzed with a
computer programe based on a multiple decision
procedure proposed by Frei and Würgler (33). This
method tests 2 alternative hypotheses: (i) the mutation
frequency in the treated group is no higher than the
mutation frequency in the control group; and (ii) the
frequency in the treated group is no less than m times as
high as the observed spontaneous mutation frequency in
the control. For the statistical calculations the conditional
binomial test, according to Kastenbaum and Bowman
(34), was used with 5 % significance levels.

Results
The results obtained regarding the mutagenic and
antimutagenic effects evaluation of ascorbic acid are
shown in Tables 1-3
The results obtained with EMS are indicated in Table
1. Under our test conditions EMS was shown to be clearly
genotoxic are increased the frequency of the 3 types of
spots recorded. The results obtained from the negative
control and optimum concentration of ascorbic acid did
not differ from each other. Although 0.5 mM
concentrations of EMS increased the mutation frequency
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Table 1. Genotoxicity of EMS and the effect of co-treatment with ascorbic acid (AA).
Compound conc.
(mM)

No. of
wings

Small single
spots (m 2)

(N)

No.

Fr.

Dist. Water

80

18

(0.23)

17 mM Ascorbic. Acid

80

18

(0.23)

0.5 mM EMS

80

40

17 mM AA + EMS

80

23

Large single
spots m 5)
D.

No.

Fr.

2

(0.03)

i

1

(0.01)

(0.50)

+

13

(0.29)

i

5

Twin spots
(m 5)
D.

No.

Fr.

1

(0.01)

-

1

(0.01)

(0.16)

+

7

(0.06)

i

4

Total mwh spots
(m 2)
D.

No.

Fr.

21

(0.26)

i

20

(0.25)

(0.09)

+

55

(0.05)

i

30

Total spots
(m 2)

D.

Frequency
of clone
formation per
D.
105 cells

No.

Fr.

22

(0.27)

-

20

(0.25)

-

1.025

(0.69)

+

60

(0.75)

+

2.218

(0.37)

i

32

(0.40)

i

1.537

1.127

conc., concentration; No., number of clones; Fr., frequency; D., statistical diagnosis according to Frei and Würgler (1988): + positive; - negative;
i, inconclusive; m multiplication factor; probability levels α = β = 0.05.

Table 2. Genotoxicity of MMS and the effect of co-treatment with ascorbic acid (AA).
Compound conc.
(mM)

No. of
wings

Small single
spots (m 2)

(N)

No.

Fr.

Dist. Water

80

18 (0.23)

17 mM Ascorbic. Acid
0.1 Mm

80

18 (0.23)

0.1 Mm MMS
17 mM AA + MMS

Large single
spots m 5)
D.

Twin spots
(m 5)

No.

Fr.

2

(0.03)

i

1

(0.01)

80

37 (0.46) +

9

(0.11) +

5

80

20 (0.25)

3

(0.04)

0

i

D.

-

i

No.

Fr.

1

(0.01)

1

(0.01)

Total mwh spots
(m 2)
D.

No.

Fr.

Total spots
(m 2)

D.

21 (0.26)
i

No.

Fr.

Frequency
of clone
formation per
D.
105 cells

22 (0.27)

20 (0.25)

-

(0.06) +

49 (0.61)

+

51 (0.64) +

2.510

(0.00)

23 (0.29)

i

23 (0.29)

1.178

-

20 (0.25)

1.127
-

i

1.025

conc., concentration; No., number of clones; Fr., frequency; D., statistical diagnosis according to Frei and Würgler (1988): + positive; - negative;
i, inconclusive; m multiplication factor; probability levels α = β = 0.05.

Table 3. Genotoxicity of ENU and effect the of co-treatment with ascorbic acid (AA).
Compound conc.
(mM)

No. of
wings

Small single
spots (m 2)
Fr.

Large single
spots m 5)

(N)

No.

Dist. Water

80

18 (0.23)

17 mM Ascorbic. Acid
0.01 mM

80

18 (0.23)

0.01 Mm ENU

80

38 (0.48) +

10 (0.13) +

6

17 mM AA+ENU

80

9

5

1

(0.11)

D.

i

-

No.

Fr.

2

(0.03)

1

(0.01)

Twin spots
(m 5)

(0.06)

D.

-

i

No.

Fr.

1

(0.01)

1

(0.01)

Total mwh spots
(m 2)
D.

No.

Fr.

Total spots
(m 2)

D.

21 (0.26)
i

No.

Fr.

Frequency
of clone
formation per
D.
105 cells

22 (0.27)

20 (0.25)

-

(0.08) +

50 (0.63)

+

54 (0.68) +

2.561

(0.01)

15 (0.19)

-

15 (0.19)

0.768

i

20 (0.25)

1.127
-

-

1.025

conc., concentration; No., number of clones; Fr., frequency; D., statistical diagnosis according to Frei and Würgler (1988): + positive; - negative;
i, inconclusive; m multiplication factor; probability levels α = β = 0.05.
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in 5 categories, co-treatments of EMS with 17 mM
concentrations of ascorbic acid drastically reduced the
frequency of mutant clones induced by EMS towards the
control value. Under the effect of ascorbic acid, the
mutation rate decreased to 42.5 %, 61.5 %, 42.9 %,
45.5 %, 46,7 % for small single spots, large single spots,
twin spots, mwh spots, and total spots respectively
(Figure).
Under our experimental conditions 0.1 mM MMS is
shown to be clearly genotoxic Table 2. Nevertheless, the
results from co-treatment of MMS with the
concentrations of ascorbic acid shown indicate that the
mutation rates are not statistically different from the
negative control in all categories. Ascorbic acid decreased
the mutation rate to 45.9 %- 66.7 %.
In our experiment, a 0.01 mM concentration of ENU
was shown to be clearly genotoxic (Table 3), inducing
significant increases in the frequency of all the types of
mutant clones recorded and the frequency of clone
formation. Our results in the co-treatment experiments
show that ascorbic acid reduced the genotoxicity of ENU
in all types of mutant clones.

Discussion

aa

0

—

—

aa + enu

10

—

—

enu

20

—

—

aa + mms

30

—

—

—

40

mms

—

—

50

aa + ems

—

—

60

Total results

ems

—

—

70

control

Number of total mutant
clones

The antimutagenic activity of ascorbic acid has been
extensively studied using both in vivo and in vitro
systems, but there are not enough data on its
antimutagenic effects in in vivo systems. The present
study was designed to determine the effect of ascorbic

Applications

Figure 1. The antimutagenic effect of ascorbic acid (aa) against 3
alkylating agents (EMS, MMS, ENU).
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acid on the mutagenicity of direct-acting alkylating agents
(EMS, MMS and ENU) that are mutagenic both in vivo
and in vitro.
Ascorbic acid is readily absorbed when the quantities
ingested are small, but limited intestinal absorption
occurs when excess amounts of ascorbic acid are
ingested. Bioavailability of ascorbic acid in food is limited,
but 80-90 % appears to be absorbed. Ascorbic acid is
widely distributed throughout the tissues, both in animals
capable of synthesizing ascorbic acid as well as in those
dependent on an adequate dietary amount of vitamin C
(35).
Antioxidants may reduce mutation induction by
chemicals in different ways: (1) competition with the
nucleophilic sites on DNA for an elecrophilic mutagen; (2)
inhibition of promutagen bioactivation by blocking
oxidation processes; (3) reaction with the electrophilic
metabolite(s) of a promutagen (36). Mechanisms 2 and 3
may be involved when promutagens need activation
whereas mechanism 1 rather concerns direct acting
mutagens such as EMS, MMS and ENU. As a physiological
molecule, ascorbic acid contributes to the natural
antioxidant defense in cells (37). It inhibits the mutagenic
activity of several N-nitroso compounds and other
carcinogens such as benzo(a)pyrene and aflatoxine
B1(38-40). Findings by Duthie et. al. (41) that both hprt
mutant frequency and lymphocyte plating efficiency were
weakly inversely associated with plasma ascorbic acid
levels suggest that ascorbic acid may be protective against
mutation at the hprt locus. It is also able to protect
against in vivo nitrosation products of methyl urea in
combination with sodium nitrite in the Drosophila wing
SMART (25). The majority of previous studies shown the
radical scavenging effects of ascorbic acid protect the cell
from mutation mediated by radicals, but the results in
this paper showed that its protective effects work not
only against the reactive oxygen species, but also against
direct acting mutagens.
Under physiological conditions ascorbic acid effectively
competes with the alkylation of cellular nucleophilic sites
such as those on DNA, RNA and proteins (42), thus
masking these sites from binding by the mutagens.
Therefore, the antimutagenic action of ascorbic acid
against EMS, MMS and ENU may be related to its ability
to block the covalent binding of tested direct alkylating
agents to cellular DNA. The results presented indicate that
EMS, MMS and ENU showed substantial mutagenicity

B. KAYA

responses in Drosophila SMART assay. The results
observed from EMS, MMS and ENU were compatible with
our previous data (43). Treatment of larvae with 72 ± 4
h of mutagenic doses of EMS, MMS and ENU in
combination with 17 mM of ascorbic acid
supplementation clearly reduced the mutation frequencies
as shown in the Figure and Table 1-3.
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Finally, and from the results reported here, it should
be noted that the Drosophila wing SMART is suitable for
detecting the antimutagenic effects of some chemicals.
Moreover, our results are of interest when investigating
the different ways in which ascorbic acid can interfere in
vivo with the mechanism of genotoxic agents.
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